IP Library › Granted Patent US 11,364,030
Granted Patent B2
US 11,364,030 · App. 16/791,824 · Granted Jun 21, 2022

Medical device for treating esophageal atresia

Inventors: Michael Walsh (Corofin, IE); Martyn G. Folan (Galway, IE)
Assignee: BOSTON SCIENTIFIC SCIMED, INC.
A61B17/1114A61B2017/00526A61B2017/1132
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,364,030
App. No.
16/791,824
Granted
Jun 21, 2022
Kind
B2
Abstract

A medical device for treating esophageal atresia may include a woven tubular member having a first end, a second end, and a body portion extending between the first end and the second end. The first end may have a first flange extending radially outwardly from the body portion. The second end may have a second flange extending radially outwardly from the body portion. The woven tubular member may be configured to transition from an initially-deployed state toward an equilibrium state. In the initially-deployed state, the body portion may include an inner region extending from the first flange to a transition region and an outer region extending from the second flange to the transition region. The outer region may surround the inner region. The woven tubular member may be self-biased to be in the equilibrium state.

Claims (43)

1. A medical device for treating esophageal atresia, comprising:

a woven tubular member having a first end, a second end, and a body portion extending between the first end and the second end;

the first end having a first flange extending radially outwardly from the body portion;

the second end having a second flange extending radially outwardly from the body portion;

wherein the woven tubular member is configured to transition from an initially-deployed state toward an equilibrium state;

wherein in the initially-deployed state, the body portion includes an inner region extending from the first flange to a transition region and an outer region extending from the second flange to the transition region;

wherein the outer region surrounds the inner region;

wherein the woven tubular member is self-biased to be in the equilibrium state;

wherein an axial length of the inner region decreases and an axial length of the outer region increases as the woven tubular member transitions from the initially-deployed state toward the equilibrium state.

2. The medical device of claim 1 , wherein in the equilibrium state, the first flange is disposed within the outer region.

3. The medical device of claim 1 , further comprising a covering disposed on at least a portion of the woven tubular member.

4. The medical device of claim 3 , wherein at least one of the first flange and the second flange includes the covering.

5. The medical device of claim 3 , wherein the covering at least partially encapsulates the woven tubular member.

6. The medical device of claim 1 , wherein an outer diameter of the inner region increases as its axial length decreases.

7. The medical device of claim 1 , wherein a portion of the body portion is everted from the inner region to the outer region as the woven tubular member transitions from the initially-deployed state toward the equilibrium state.

8. A medical device for treating esophageal atresia, comprising:

a woven tubular member having a first end, a second end, and a body portion extending between the first end and the second end;

the first end having a first flange extending radially outwardly from the body portion;

the second end having a second flange extending radially outwardly from the body portion; and

the body portion having an inner region extending from the first flange to a transition region and an outer region extending from the second flange to the transition region;

wherein the outer region surrounds the inner region;

wherein the woven tubular member is configured to transition from an initially-deployed state toward an equilibrium state;

wherein in the initially-deployed state, the woven tubular member has a proximalmost extent and a distalmost extent, the second flange being positioned at a location intermediate the proximalmost extent and the distalmost extent;

wherein a portion of the body portion is everted from the inner region to the outer region as the woven tubular member transitions from the initially-deployed state toward the equilibrium state.

9. The medical device of claim 8 , wherein the first flange moves toward the second flange as the woven tubular member transitions from the initially-deployed state toward the equilibrium state.

10. The medical device of claim 9 , wherein the outer region of the woven tubular member surrounds the first flange in the equilibrium state.

11. The medical device of claim 10 , wherein an outer diameter of the inner region increases as the woven tubular member transitions from the initially-deployed state toward the equilibrium state.

12. A medical device for treating esophageal atresia, comprising:

a woven tubular member having a first end, a second end, and a body portion extending between the first end and the second end;

the first end having a first flange extending radially outwardly from the body portion;

the second end having a second flange extending radially outwardly from the body portion;

wherein the woven tubular member is configured to transition from an initially-deployed state toward an equilibrium state;

wherein in the initially-deployed state, the body portion includes an inner region extending from the first flange to a transition region and an outer region extending from the second flange to the transition region;

wherein the outer region surrounds the inner region;

wherein the woven tubular member is self-biased to be in the equilibrium state;

wherein a portion of the body portion is everted from the inner region to the outer region as the woven tubular member transitions from the initially-deployed state toward the equilibrium state.

13. The medical device of claim 12 , wherein in the equilibrium state, the first flange is disposed within the outer region.

14. The medical device of claim 12 , further comprising a covering disposed on at least a portion of the woven tubular member.

15. The medical device of claim 14 , wherein at least one of the first flange and the second flange includes the covering.

16. The medical device of claim 14 , wherein the covering at least partially encapsulates the woven tubular member.

17. The medical device of claim 12 , wherein an outer diameter of the inner region increases as its axial length decreases.

18. The medical device of claim 12 , wherein the first flange moves toward the second flange as the woven tubular member transitions from the initially-deployed state toward the equilibrium state.

19. The medical device of claim 18 , wherein the outer region of the woven tubular member surrounds the first flange in the equilibrium state.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2020
From: WALSH, MICHAEL; FOLAN, MARTYN G.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 051826/0128 →
Continuity (2)
Provisional Application 62806599 · Feb 15, 2019
Related Publication 20200261092A1 · Aug 20, 2020